Intravenous artesunate reduces parasite clearance time, duration of intensive care, and hospital treatment in patients with severe malaria in Europe: The TropNet severe malaria study

Clinical Infectious Diseases

Volumn 61, Issue 9, 2015, Pages 1441-1444

  Kurth, Florian ^a   Develoux, Michel ^b   Mechain, Matthieu ^c   Clerinx, Jan ^d   Antinori, Spinello ^e   Gjørup, Ida E ^f   Gascon, Joaquím ^g   Mørch, Kristine ^h   Nicastri, Emanuele ⁱ   Ramharter, Michael ^j   Bartoloni, Alessandro ^k   Visser, Leo ^l   Rolling, Thierry ^m,n   Zanger, Philipp ^o,p   Calleri, Guido ^q   Salas Coronas, Joaquín ^r   Nielsen, Henrik ^s   Just Nübling, Gudrun ^t   Neumayr, Andreas ^u   Hachfeld, Anna ^v   Schmid, Matthias L ^w   Antonini, Pietro ^x   Pongratz, Peter ^a   Kern, Peter ^y   Saraiva Da Cunha, José ^z   Soriano Arandes, Antoni ^aa   Schunk, Mirjam ^ab   Suttorp, Norbert ^a   Hatz, Christoph ^u   Zoller, Thomas ^u   more..

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HÔPITAL SAINT ANTOINE   (France)

^c University Hospital Centre   (France)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^e UNIVERSITY OF MILAN   (Italy)

^f GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^g CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^h HAUKELAND UNIVERSITY HOSPITAL   (Norway)

ⁱ NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^j MEDICAL UNIVERSITY OF VIENNA   (Austria)

^k CAREGGI UNIVERSITY HOSPITAL   (Italy)

^l LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^m UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

ⁿ BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^o UNIVERSITY OF HEIDELBERG   (Germany)

^p UNIVERSITY OF TÜBINGEN   (Germany)

^q AMEDEO DI SAVOIA HOSPITAL   (Italy)

^r HOSPITAL DE PONIENTE   (Spain)

^s AALBORG UNIVERSITY HOSPITAL   (Denmark)

^t UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^u SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^v UNIVERSITY OF BERN   (Switzerland)

^w ROYAL VICTORIA INFIRMARY   (United Kingdom)

^x Reparto di Chirurgia Ortopedica   (Switzerland)

^y UNIVERSITY HOSPITAL ULM   (Germany)

^z CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^aa HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^ab UNIVERSITY OF MUNICH   (Germany)

more..

Author keywords

artesunate; clinical study; Plasmodium falciparum; quinine; severe malaria

Indexed keywords

ARTESUNATE; QUININE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

ADULT; ARTICLE; BRAIN MALARIA; DISEASE SEVERITY; HOSPITAL CARE; HUMAN; HYPOGLYCEMIA; INTENSIVE CARE; INTENSIVE CARE UNIT; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; MIGRATION; PARASITE CLEARANCE; PARASITEMIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; SURVIVAL RATE; TOURISM; TREATMENT DURATION; CLINICAL TRIAL; EUROPE; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; RETROSPECTIVE STUDY; TIME FACTOR; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVENOUS; ADULT; ANTIMALARIALS; ARTEMISININS; EUROPE; FEMALE; HUMANS; MALARIA; MALE; QUININE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84946721569     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ575     Document Type: Article

References (11)

1. Dondorp A, Nosten F, Stepniewska K, Day N, White N; South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) Group. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 2005; 366:717-25.
2. Dondorp AM, Fanello CI, Hendriksen IC, et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 2010; 376:1647-57.
3. Zoller T, Junghanss T, Kapaun A, et al. Intravenous artesunate for severe malaria in travelers, Europe. Emerg Infect Dis 2011; 17:771-7.
4. Rolling T, Schmiedel S, Wichmann D, Wittkopf D, Burchard G-D, Cramer JP. Post-Dreatment haemolysis in severe imported malaria after intravenous artesunate: case report of three patients with hyperparasitaemia. Malar J 2012; 11:169.
5. Kreeftmeijer-Vegter AR, van Genderen PJ, Visser LG, et al. Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium. Malar J 2012; 11:102.
6. World Health Organization. Guidelines for the treatment of malaria. Geneva, Switzerland: WHO, 2006.
7. Eder M, Farne H, Cargill T, Abbara A, Davidson RN. Intravenous artesunate versus intravenous quinine in the treatment of severe falciparum malaria: a retrospective evaluation from a UK centre. Pathog Glob Health 2012; 106:181-7.
8. Centers for Disease Control and Prevention. Artesunate is available to treat severemalaria in the United States. Available at: http://www.cdc.gov/malaria/diagnosis-Dreatment/artesunate.html. Accessed 28 January 2015.
9. Marks ME, Armstrong M, Suvari MM, et al. Severe imported falciparum malaria among adults requiring intensive care: a retrospective study at the hospital for tropical diseases, London. BMC Infect Dis 2013; 13:118.
10. Kohlenberg A, Schwab F, Behnke M, Geffers C, Gastmeier P. Pneumonia associated with invasive and noninvasive ventilation: an analysis of the German nosocomial infection surveillance system database. Intensive Care Med 2010; 36:971-8.
11. Mühlberger N, Jelinek T, Behrens RH, et al. Age as a risk factor for severe manifestations and fatal outcome of falciparum malaria in European patients: observations from TropNetEurop and SIMPID Surveillance Data. Clin Infect Dis 2003; 36:990-5.